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ABSTRACT 
This study aims to model the derived compounds of 1,2,3-triazolopiperidine using semiempirical 
method AM1 and determine the further derivation with the better IC50 values against DPP-4 enzyme 
theoretically. This research employed ChemDraw Pro 12 software for for 2D structural drawing, 
Hyperchem 8.0 for 3D modelling, and MLR statistical analysis for modeling QSAR equations. The 
semiempirical method was likely to be the appropriate platform to apply because the correlation 
coefficient of H1 NMR chemical shift between theoretical and actual value is relatively close, 0.8891. 
The multilinear regression analysis produced 4 equation models where the best one is equation 4 
as detailed below:” IC50   = 875.5116 + (-7400.27*qH35) + (-0.00133* Eat.is) + (-3230.72* qN23) + 
(3.30277* µ)” n = 25; r2 = 0.594; Adjusted r2= 0.486; PRESS = 1.2× 104. Finally, the theoretically 
promising substituent was -CN possessing IC50 value = 1.61 nM.  
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INTRODUCTION 
QSAR (quantitative structure and ac-
tivity relationship) has been designed to 
quantify a consistent relationship between 
molecular skeleton and its biological activity 
resulting an opportunity to evaluate the prop-
erties of new materials compared to a series 
of molecules being modeled [1,2]. The QSAR 
method can also allow chemists working in 
synthetic field to improve their desired prod-
ucts performance by modelling the molecules 
through appropriates approach [3,4]. There-
fore, validating methods applied in a compu-
tational project is a vital step that mainly drive 
the accuracy of the output. 
Generally, validation of computer-assisted 
modelling methods in such field is likely to be 
carried-out by comparing the computed data 
with the experimental observation [5]. One of 
the reliable approach is comparison the 
chemical shift value of nuclear magnetic 
resonance (NMR) between calculated and 
actual data. Through statistical analysis, the 
most appropriate method could be determined 
by observing the correlation coefficient (r2) 
number [6].   
QSAR seems to be powerful tool for 
predicting drug compounds and the efficacy 
for treating deadly diseases like type 2 
diabetes mellitus (T2DM). Diabetes mellitus 
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is of metabolic diseases characterized by 
hyperglycemia due to a deficiency of insulin 
secretion, insulin resistance, or both [7,8,9, 
10]. In T2DM case, the causes may vary from 
the dominant insulin resistance accompanied 
by relative insulin deficiency to the dominant 
decrease of insulin secretion accompanied 
by insulin resistance [8,9,10]. 
Currently, one of the most effective 
oral antidiabetic therapies is by inhibiting the 
enzyme dipeptidyl peptidase-4 (DPP-4), the 
main inactivator of the degradation of 
glucagon like peptide-1 (GLP-1) and glucose-
dependent insulinotropic peptide (GIP). 
Scientific report shows that DPP-4 inhibitors 
appear to be effective in controlling blood 
glucose levels without causing weigh gain [6]. 
Sitagliptin, saxagliptin, vildagliptin and linagliptin 
are DPP-4 inhibitors available for the treatment 
of T2DM in Indonesia and many other 
countries [11,12,13]. However, those drugs 
could cause runny or stuffy nose, sore throat, 
headache, backache, stomachache, diarrhea, 
constipation, hypoglycemia, weakness, drow-
siness, and blurred vision. To reduce these 
side effects, the development of 1,2,3-
triazolopiperidine compounds, the main 
skeleton of sitagliptin, needs to be done by 
modifying the structure with the QSAR 
assistance [11,12,13] 
Such research has been carried-out on 
the compounds through the correlation of 
their structure and descriptor properties with 
experimental activities. Modeling the 
triazolopiperazin amide derivatives, similar 
compounds to 1,2,3-triazolopiperidine, has 
been accomplished using the semiempirical 
method [14]. In the term of time consuming, 
the method appears to be more efficient than 
ab-initio in the design of drug compounds. 
The research suggests that further studies of 
DPP-4 inhibitor compounds need to be 
conducted especially for other compounds 
which inhibitory mechanism and structure 
resemble triazolopiperazin compounds. 
 
METHODS  
The structure of 1,2,3-triazolopiperidine 
derivatives and their activity (IC50) were taken 
from [12]. This study employed a computer 
device with OS Windows 2010, RAM 4 GB 
DDR3L-1600, Hard Drive 500 GB. The softwares 
were ChemDraw Pro 12, Hyperchem 8.0, 
SPSS 21, and Microsoft Excel.  
 
Figure 1. The main structure of 1,2,3-triazolo-
piperidine.[15]   
 
1. Geometry optimization and predictor 
calculations 
A total of 18 derivatives of 1,2,3-
triazolopiperidine were randomly selected (2, 
3, 5, 6–19, 21–24)  (Table 1). A 2D structure 
was made using the ChemDraw Pro 12 then 
exported to Hyperchem 8.0 for structure 
optimization and calculating the required 
parameters. The optimized geometry represents 
the most stable feature. 
2. Calculation of electronic and molecular 
parameters 
A single point calculation was performed 
with the output data collected in the recording 
file (file.log) to give energy and net atomic 
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charge data. Data of partial atomic charge, 
surface area, volume, hydration energy, log P, 
molar refractivity, molecular polarizability 
and molecular mass can be seen in the 
QSAR properties of the Hyperchem 8.0 
program.
 
Table 1. Substituent list and bioactivity data of 1,2,3-triazolopiperidine series 
No             R     IC50 a (nM) No R IC50a (nM) 
1. H 89,50 14. Ph-4-CONH2 36,43 
2. CH3 77, 06 15. Ph-4-CONMe2 26,64 
3. CF2H 22,53 16. Ph-4-CO2Me 12,40 
4. CF3 50,66 17. Ph-4-COOH 33,78 
5. CO2Me 15,09 18. Ph-4-SO2Me 33,17 
6. CO2NH2 29,92 19. 4-Pyr 28,60 
7. CO2NMe2 52,34 20. 2-Pyr 33,25 
8. Ph 37,54 21. 
 
15,80 
9. Ph-4-F 45,20 22.  
 
26,17 
10. Ph-4-Cl 46,89 23. 
 
22,76 
11. Ph-4-CF3 75,35 24. 
 
47,27 
12. Ph-4-CN 30,03 25. 
 
17,83 
13. 
Ph-3- 
CO2Me 
46,61    
 
3. Calculation of 1H NMR δ of the compounds 
with semiempirical AM1 method 
The optimized structures were then 
analyzed using proton NMR chemical shift 
values (δ) and compared with experimental 
data obtained from [9] . In the program, the 
structure of 1,2,3-triazolopiperidine derivatives 
was left-clicked to select compute menu then 
followed by NMR invoke. In the new page, 
setup was clicked then select H to start the 
calculation. 
4. QSAR analysis using multiple linear 
regression analysis (MLR) 
The study used MLR analysis with 
forward method in SPSS 21 program. The 
independent variables were electronic and 
molecular parameters obtained from the 
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file.log and QSAR properties, while the 
dependent variable was IC50 values of the 
1,2,3-triazolopiperidine derivatives. 
5. Determination of the best QSAR 
equation model using electronic and 
molecular parameters 
The best model determined from the 
the QSAR analysis was gained by comparing 
its IC50 value to the experimental biological 
activity. This can be achieved from the 
correlation coefficient (r2) of the curve. 
6. Designing new compounds through 
modification of type and position of 
substituents 
Modeling new compounds by modifying 
new substituents were generated through the 
selected equation to predict their IC50 value. 
According to  [12], electronegative substituent 
groups (F, Cl, CF3 and CN) can increase the 
inhibitory property of these compounds. The 
positioning substituent focused on the active 
side of five-cycled ring due to the dense 
electron in the site. 
 
RESULTS AND DISCUSSION 
1. Validation of the method  
The outcome of method validation is 
shown in Figure 2. From the δ data of proton 
NMR, the r2 of the AM1 method has a 
relatively close to one. Statistically, this 
shows that the method met the required value 
of a validated parameter. Moreover, the AM1 
method could be considered as the accurate 
approach to compute and model organic 
molecules [16,17,18]. 
 
Figure 2. A curve illustrating the relationship 
between predictive and actual δ 
 
2. QSAR analysis data 
The resulted QSAR equation of AM1 is 
presented in Table 2. Based on the PRESS 
values, equation 4 and 5 could be taken into 
account as the proper model due to the lower 
gaps between predictive and the experiment 
value indicating the reliable model for 
computational purposes [18,19,20].  
From figure 3, model 4 could be 
considered as the best equation because of 
its slope value. The equation shows that the 
main descriptor is the bipolar moment (µ) 
indicated from the highest coefficient value. It 
refers to a potential difference between posi-
tive and the negative charge of the centre of 
atom. It is reasonable as the main descriptor 
due to the presence of conjugated ring where 
the substituents are located. The vital role of 
the conjugation seems to contribute at de-
signing new modification. Meaningly, those 
with electronic attracting capacity are taken 
into account as the potential substituents 
providing a better inhibition. 
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Table 2. Proposed QSAR model of AM1 method resulted from MLR analysis 
Model Variable r2 Adjusted r2 F calculation F table Fcal./Ftab PRESS 
1 qH35 0.25 0.208 5.994 5.317 1.127 6.2 × 104 
2 qH35, Eat.is,  0.446 0.381 6.836 3.591 1.903 11 × 104 
3 qH35, Eat.is, qN23 0.538 0.451 6.205 3.238 1.916 6.3 × 104 
4 qH35, Eat.is, qN23,µ,  0.594 0.486 5.489 3.055 1.796 1.2× 104 
5 
qH35, Eat.is, qN23,µ, 
qN22, 
0.783 0.705 10.084 2.958 3.409 1.5× 104 
6 
qH35, Eat.is, qN23,µ, 
qN22,qC20 
0.816 0.732 9.637 2.915 3.305 16 × 104 
7 
qH35, Eat.is, qN23,µ, 
qN22,qC20, MW  
0.843 0.751 9.172 2.913 
3.148 
 
36× 104 
 
 
 
Figure 3. Curves showing a relationship between predictive values of IC50 from model 4 (above) 
and model 5 (below) and actual values of the bioactivity  
 
It can be estimated that the active 
antidiabetic compounds seem to own high µ 
coefficient values. The equation can be 
expressed as: 
IC50   = 875,5116 + (-7400,27*qH35) + (-
0,00133* Eat.is) + (-3230,72* 
qN23) + (3,30277* µ) 
n = 25; r2 = 0,594; adjusted r2 = 0,486; PRESS 
= 1,2×104 
3. Designing new derivatives 
As the best QSAR equation, model 4 
was applied to design new compounds and 
predict their biological activity. The calculated 
parameters were qH35, Eat.is, qN23 and µ. 
The IC50 values of the proposed compounds 
resulted from the model can be seen in the 
Table 3. 
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Table 3. Calculated IC50 list of proposed 
derivatives of 1,2,3-triazolopiperidine 
using model 4 
 
No R Calculated IC50  (nM) 
26.  -NH2 117.6376 
27. -CH2CH3 62.85529 
28. -CH2CH2CH3 69,23759 
29. -CO2CH2CH3 29.24463 
30. -Br 26.90709 
31. -CN 1.614839 
32. -Cl 21.08032 
33. -CH2Br 30.20057 
34. -CH2CH2F       55.85733 
35. -CH2CN 13.76882 
36. -CH2Cl 33.49917 
37. -C(Cl)2 25.97308 
38. 
 
24.45556 
 
39. 
 
65.46935 
 
40. 
 
38.74836 
 
41. 
 
69.73073 
 
42. 
 
65.36978 
 
 
The new compounds designed from 
model 4 provide various IC50 values Figure 4. 
Accordingly, there is one compound 
possessing the most excellent inhibitory 
activity value theoretically of 1.61, namely 
compound 31 Table 3. The CN-substituted 
derivative offers a relatively strong hydrogen 
bonding activity linked to the properties of the 
substituent as an electronegative and non-
bulky group [21]. On the other hand, the 
compound no 26 with IC50 value > 89.50 
might be related to the NH2 group as a strong 
electron-withdrawing as well as medium size 
substituent. It might result in interference of 
interaction between the compound and the 
active site of the enzyme leading to weaker 
activity. 
DPP 4 enzyme is the responsible 
player in the GLP-1/GIP-associated insulin 
secretion in pancreas. The enzyme cleaves 
the peptide bonding if the incretins using its 
active site. The active region of the enzyme 
can be classified as five sites, namely S2 
extensive, S2 subsite, S1 subsite, S01 
subsite, and S02 subsite [22]. In details, the 
composition of them is described in Table 4.   
 
Table 4. List of identified protein composed 
active site of DPP-4 enzyme. 
No Active sites Amino acids 
1 
S2 ext. (S2 
extensive) 
Val207, Ser209, Phe357, 
Arg358 
2 S2 subsite 
Arg125, Phe357, Arg358, 
Glu205, Glu206, Arg669 
3 S1 subsite 
Ser630, Val656, Trp659, 
Tyr662, Tyr666, Val711, 
Asn710 
4 S’1 subsite 
Phe357, Tyr547, Pro550, 
Ser630, Tyr631, Tyr666 
5 S’2 subsite 
Tyr547, Trp629, Ser630, 
His740 
 
A well-accepted explanation with 
regard to the inhibition of the enzyme has 
confirmed a crucial role of the hydrophobic 
interaction and hydrogen bonding among 
DPP-4 and its inhibitors [23]. According to 
[24], physical interaction could play other 
roles in the case such as T-shaped, salt 
bridge, and cation channels. However, 
different inhibitor tends to exhibit different 
mode of action with hydrophobic and 
hydrogen bonding as the main key factor in 
the activity. 
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Figure 4. Graphic representation of IC50 of proposed compounds and the most actual compound  
 
As mentioned by Arulmozhiraja and 
colleagues (2016), Sitagliptin, as the another 
derivative of triazolopiperazine, demonstra-
tes both van der Waals dispersion and 
electronic interaction to bind protease sites of 
the enzyme. Regarding the compound 31, 
cyano group manifests the role of chain-like 
network pattern provided by atom N to 
electronically interact with hydrogen atoms in 
the active sites of the enzyme [25]. Such 
interaction may lead to stronger connection 
between inhibitor and the amino acids of the 
target.    
 
CONCLUSION  
This study confirms that semiempirical 
AM1 method can be applied to conduct an 
QSAR analysis of 1,2,3-triazolopiperidine 
derivatives and forecast the alternatively new 
derivatives owning potential bioactivity as the 
inhibitor of DPP 4 enzyme. The method 
proposed the best equation as following as:  
IC50   = 875,5116 + (-7400,27*qH35) + (-
0,00133* Eat.is) + (-3230,72* 
qN23) + (3,30277* µ) 
n = 20; r2 = 0,594; adjusted r2 = 0,486; PRESS 
= 1,2× 104 
Theoretically, the research offer a new 
compound with –CN as the alternative 
substituent to obtain the better value of the 
inhibitory activity. Further attempts are 
needed to confirm the feasibility and also the 
activity of the proposed species through 
laboratory work.  
 
REFERENCES  
[1]   H. D. Pranowo, Pengantar Kimia 
Komputasi, Bandung: Lubuk Agung, 
2011. 
 
[2] S. B. Utomo, F. Sanubari, B. Utami,  & 
N. D. Nurhayati, “ Analysis of a 
quantitative relationship between the 
structure and analgesic activity of 
meperidin derivatives using semi-
empirical AM1 method”,  JKPK (Jurnal 
Kimia dan Pendidikan kimia), vol. 2, 
no. 3, pp. 158-168, 2017. 
 DOI: 10.20961/jkpk.v2i3.12092  
 
[3] M. D. Breyer,” Improving productivity of 
modern-day drug discovery”, Expert 
Opinion on Drug Discovery, vol. 9, no. 
2, pp.115-118, 2014 
. DOI: 10.1517/17460441.2014.870150  
 
0
20
40
60
80
100
120
140
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 16
IC
5
0
(n
M
)
No of compound
  JKPK (JURNAL KIMIA DAN PENDIDIKAN KIMIA), Vol. 5, No. 1, 2020,  pp. 70-78          77 
[4] W. Hui, M. Jiang, F. Sun, S. Li, C.Y. 
Hse, & C. Jin, “Screening, synthesis, 
and QSAR research on cinnamal-
dehyde-amino acid schiff base com-
pounds as antibacterial agents. 
Molecules, vol. 23, no.11, 2018. 
 DOI:10.3390/molecules23113027  
 
[5]   A. P. Asmara, Mudasir, & D. Siswanta, 
”Penentuan metode komputasi untuk 
analisis hubungan kuantitatif struktur 
dan aktivitas senyawa turunan 
triazolopiperazin amida”. Elkawnie: 
Journal of Islamic Science and 
Technology, vol. 1, no.1, pp19-30, 2015. 
 DOI:10.22373/ekw.v1i1.515  
 
[6]   H. D. Pranowo, Kimia Komputasi. 
Yogyakarta: Pusat Kimia Komputasi 
UGM, 2000. 
 
[7]  P. N. Malani. “Harrison’s Principles of 
Internal Medicine”, JAMA. vol.308, 
no.17, pp. 1813–1814,2012. 
DOI:10.1001/jama.308.17.1813-b  
 
[8]  C. D.A. Stehouwer & N. C. Schaper, 
Therapeutic strategies in Diabetes. 
Oxford: Clinic.al Publishing, 2009. 
 
[9] H. Yehuda, & Z. Bloomgarden, “ 
Diabetes In Youth: A Dilemma Of 
Pathogenesis”. Juornal Of Diabetes. 
Metabolic Institute Of America, 
vol.3, no 2, pp 91-92, 2011. 
 DOI:10.1111/j.1753-0407.2011.00127.x  
 
[10]  Roglic, Gojka. "WHO Global report on 
diabetes: A summary." International 
Journal of Noncommunicable Diseases, 
vol.1, no.1, pp3-8, 2016. 
 
[11] J. J. Neumiller, L. Wood, & R. K. 
Campbell, “Dipeptidyl peptidase 4 
(DPP-4) inhibitors for the treatment of 
type 2 diabetes mellitus”, Pharmacotherapy, 
vol. 30, no.5, pp463-484,2010. 
 DOI:10.1592/phco.30.5.463  
 
[12]  Z. Shan, M. Peng, H. Fan, Q. Lu, P. Lu, 
C. Zhao, & Y.Chen, ”Discovery of 
potent dipeptidyl peptidase IV inhibitors 
derived for the treatment of type 2 diabetes, 
Bioorganic & Medicinal Chemistry Letters, 
vol 21, no.6, pp 1731–1735, 2011. 
 DOI:10.1016/j.bmcl.2011.01.086  
 
 
[13]  S. A. El-Karim, Y. M. Syama, M. A. 
Nael,  H. F. Ali, & M. A. Motaleb, “ 
Rational design and synthesis of new 
tetralin-sulfonamide derivatives as po-
tent antidiabetics and DPP-4 inhibitors: 
2D&3D QSAR, in vivo radiolabeling 
and bio distribution studies”, Bioorganic 
Chemistry, vol. 81, pp. 481-493, 2018. 
 DOI:10.1016/j.bioorg.2018.09.021    
 
[14] A. P. Asmara, Mudasir, & D. Siswanta, 
“Analisis HKSA senyawa antidiabetik 
turunan triazolopiperazin amida meng-
gunakan metode semiempirik PM3. Al-
Chemy: Journal of Chemistry, vol. 5, 
no. 4, pp. 106–113, 2017. 
 DOI:10.18860/al.v5i4.4045 
 
[15] K. Wijaya, I. Tahir, B. Purwono, & W. 
Dinni,” QSAR study of flavone/flavonol 
analogues as the antiradical compounds 
based on Hansch analysis”, Indonesian 
Journal of Chemistry, vol. 3, no. 1, pp. 
48-54, 2003. 
 DOI:10.22146/ijc.21905  
 
[16]  F. Jensen, Introduction to Computational 
Chemistry. West Sussex: John Wiley & 
Sons, 2007. 
 
[17]  I. Tahir & P.  Iswanto, “Hubungan 
kuantitatif struktur dan aktivitas anti-
kanker senyawa turunan estradiol 
hasil perhitungan metode semiempiris 
AM1. Yogyakarta: Prosiding Seminar 
Nasional Kimia XV, ISSN 1410-8313, 
2004. 
 
[18]  P. E. Istyastono, S. Martono,  H. D. 
Pranowo, & I. Tahir, “Quantitative 
structure-activity relationship analysis 
of curcumin and its derivatives as gst 
inhibitors based on computational 
chemistry calculation”. Indonesian 
Journal of Chemistry, vol. 3, no. 3, pp. 
179-186, 2003. 
 DOI:10.22146/ijc.21886  
 
[19]  H. D. Siswandono,  Kimia Medisinal, 
Surabaya: Universitas Airlangga Press, 
2000. 
 
[20] G. L Patrick, An Introduction to Medicinal 
Chemistry, Oxford: Oxford University 
Press, 2013. 
 
 
 
78 A. P. Asmara, et al., QSAR Modeling of Compounds Derived ...........          
 
[21]  C. Li, M. Hanif, X. Li, S. Zhang, Z. Xie, 
L. Liu, B. Yang, S. Su, & Y. Ma, “ Effect 
of cyano-substitution in distyrylbenzene 
derivatives on their fluorescence and 
electroluminescence properties”. Journal 
of Materials Chemistry C, vol. 4, no. 31, 
pp. 7478–7484, 2016. 
 DOI:10.1039/C6TC01886F 
 
[22] S. Arulmozhiraja, N. Matsuo, E. 
Ishitsubo, S. Okazaki, H. Shimano,  & 
H. Tokiwa, “Comparative Binding 
Analysis of Dipeptidyl Peptidase IV 
(DPP-4) with Antidiabetic Drugs – An 
Ab Initio Fragment Molecular Orbital 
Study. PLoS ONE, vol.11, no.11, 2016. 
DOI:10.1371/journal.pone.0166275  
 
[23] K. Aertgeerts, S. Ye, M. G. Tennant, M. 
L. Kraus, J. O. E. Rogers, B. C. Sang, 
R. J. Skene, D. R. Webb, & G. S. 
Prasad, “Crystal structure of human 
dipeptidyl peptidase IV in complex with 
a decapeptide reveals details on 
substrate specificity and tetrahedral 
intermediate formation”, Protein Science, 
vol.13, no.2, pp. 412–421, 2004.  
DOI :10.1110/ps.03460604 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[24] S. Q. Pantaleão, E .A. Philot, D. 
Resende-Lara, P. Túlio, A. N. Lima, D. 
Perahia, M. A. Miteva, A. L. Scott, & K. 
M. Honorio, ”Structural dynamics of 
DPP-4 and its influence on the projection 
of bioactive ligands”, Molecules, vol. 23, 
no.2, pp. 490, 2018. 
 DOI:10.3390/molecules23020490 
 
[25] D. Bhattacherjee, C. Basu, Q. Bhardwaj, 
S. Mal, S. Sahu, R. Sur, & K. P. 
Bhabak, “Design, Synthesis and Anti‐
Cancer Activities of Benzyl Analogues 
of Garlic‐Derived Diallyl Disulfide (DADS) 
and the Corresponding Diselenides”,  
Chemistry Select, vol. 2. no. 24, pp. 
7399–7406, 2017.  
 DOI:10.1002/slct.201700499 
